1. LBA-002Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study. (2nd July 2019) Authors: Tabernero, J; Van Cutsem, E; Bang, Y; Fuchs, C; Wyrwicz, L; Lee, K; Kudaba, I; Garrido, M; Chung, H; Castro Salguero, H; Mansoor, W; Braghiroli, M; Goekkurt, E; Chao, J; Wainberg, Z; Kher, U; Shah, S; Kang, S; Shitara, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗